» Authors » Jonas Pettersson

Jonas Pettersson

Explore the profile of Jonas Pettersson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 2362
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pernet O, Weisenhaus M, Stafylis C, Williams C, Campan M, Pettersson J, et al.
Sci Rep . 2023 May; 13(1):7612. PMID: 37165019
Epidemiologic surveillance of circulating SARS-CoV-2 variants is essential to assess impact on clinical outcomes and vaccine efficacy. Whole genome sequencing (WGS), the gold-standard to identify variants, requires significant infrastructure and...
2.
Tehranchi R, Pettersson J, Melgaard A, Seitz F, Valeur A, Maarbjerg S
Curr Ther Res Clin Exp . 2022 Apr; 96:100668. PMID: 35464292
Background: Dasiglucagon is a novel glucagon analog that is stable in aqueous formulation and approved for use in severe hypoglycemia. Concentration QTc analyses are critical for assessing risk of drug-induced...
3.
Demmel V, Sandberg-Schaal A, Jacobsen J, Golor G, Pettersson J, Flint A
Diabetes Ther . 2018 May; 9(4):1441-1456. PMID: 29799100
Introduction: Semaglutide is a glucagon-like peptide-1 (GLP-1) analog approved for the once-weekly treatment of type 2 diabetes. The objective of this 16-week, double-blind, single-center thorough QT study was to confirm...
4.
Jensen L, Kupcova V, Arold G, Pettersson J, Hjerpsted J
Diabetes Obes Metab . 2017 Dec; 20(4):998-1005. PMID: 29205786
Aims: To investigate whether the pharmacokinetic characteristics of semaglutide were altered in people with hepatic impairment, assessed using Child-Pugh criteria, vs those with normal hepatic function. Methods: In this multicentre,...
5.
Emerson J, Abbaszadeh Y, Lo J, Tsinas Z, Pettersson J, Ward P, et al.
J Mater Sci Mater Med . 2017 Oct; 28(12):185. PMID: 29039618
We have developed novel photopolymer gels to function as separators in blood collection tubes. By incorporating antioxidants such as α-tocopherol and nitroxides (TEMPO and TEMPOL), the new formulation can be...
6.
Pettersson J, Bjorkander E, Bark S, Holmgren D, Wekell P
J Med Libr Assoc . 2017 Jul; 105(3):262-267. PMID: 28670215
Background: Traditionally, teaching hospital staff to search for medical information relies heavily on educator-defined search methods. In contrast, the authors describe our experiences using real-time scenarios to teach on-call consultant...
7.
Wei C, Pettersson J, Campan M, Chopra S, Naritoku W, Martin S, et al.
Appl Immunohistochem Mol Morphol . 2016 Dec; 26(8):573-578. PMID: 28027118
Patients with succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumor (GIST) have few therapeutic options. Despite lack of KIT or platelet-derived growth factor receptor A (PDGFRA) driver mutations, SDH-deficient GISTs display strong...
8.
Pahlm O, Swenne C, Man S, Fakhri Y, Atwater B, Bacharova L, et al.
J Electrocardiol . 2016 Dec; 50(1):47-73. PMID: 28010929
No abstract available.
9.
Marso S, Bain S, Consoli A, Eliaschewitz F, Jodar E, Leiter L, et al.
N Engl J Med . 2016 Sep; 375(19):1834-1844. PMID: 27633186
Background: Regulatory guidance specifies the need to establish cardiovascular safety of new diabetes therapies in patients with type 2 diabetes in order to rule out excess cardiovascular risk. The cardiovascular...
10.
Liu Y, Yen H, Austria T, Pettersson J, Peti-Peterdi J, Maxson R, et al.
EBioMedicine . 2015 Dec; 2(10):1318-30. PMID: 26629527
Predisposition to breast and extrauterine Müllerian carcinomas in BRCA1 mutation carriers is due to a combination of cell-autonomous consequences of BRCA1 inactivation on cell cycle homeostasis superimposed on cell-nonautonomous hormonal...